Insider Shareholders with Direct Ownership of Windtree Therapeutics Inc (WINT)
This section provides a comprehensive overview of the insiders with direct ownership of Windtree Therapeutics Inc (WINT). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
WINDTREE THERAPEUTICS INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Center Laboratories, Inc.
> 10% Shareholder |
1,239,088 | 0 | 1,239,088 $396,508 | 1 |
Dec 30, 2021
Added 50.0%
|
|
James Huang
Director |
206,000 | 0 | 296,281 $94,809 | 4 |
Jun 07, 2022
Added 1.66%
|
|
John P. Hamill
SVP & CFO |
72,800 | 0 | 72,800 $23,296 | 5 |
Jul 26, 2022
Added 3.96%
|
|
Steven Simonson
SVP, Chief Medical Officer |
88,667 | 100 | 17,440 $5,580 | 5 |
Aug 23, 2023
Added 47.64%
|
|
Eric Curtis
SVP & COO |
82,258 | 99 | 15,920 $5,094 | 5 |
Aug 23, 2023
Added 47.95%
|
|
Craig Fraser
President and CEO |
262,120 | 334 | 8,638 $2,764 | 28 |
Oct 08, 2024
Added 38.6%
|
|
Mark Strobeck
Director |
2,300 | 0 | 2,300 $736 | 1 |
Aug 23, 2023
Added 50.0%
|
|
Daniel E. Geffken
Director |
7,033 | 0 | 2,175 $696 | 2 |
Aug 23, 2023
Added 48.31%
|
|
Robert A Scott
Director |
7,033 | 0 | 2,133 $682 | 2 |
Aug 23, 2023
Added 48.8%
|
|
Leslie J. Williams
Director |
7,033 | 0 | 2,133 $682 | 2 |
Aug 23, 2023
Added 48.8%
|
|
Diane Carman
SVP & General Counsel |
66,300 | 99 | 1,227 $392 | 2 |
Feb 28, 2023
Reduced 7.47%
|
|
Bioengine Capital Inc.
> 10% Shareholder |
55,172 | 4,790,838 | 0 $0 | 3 |
Dec 30, 2021
Reduced 100.0%
|